The remarkable specificity and safety of antibody drugs have been limited to blocking inactivators for the largest class of drug targets. Abalone Bio develops antibody drugs that activate, enabling us to turn on previously inaccessible biological activities like anti-cancer or anti-inflammatory actions.
| Website | https://www.abalonebio.com |
| Employees | 23 (17 on RocketReach) |
| Founded | 2017 |
| Address | 1250 45th St Ste 520, Emeryville, California 94608, US |
| Technologies |
JavaScript
,
HTML
,
Twitter
+16 more
(view full list)
|
| Industry | Biotechnology Research, Software |
| Competitors | Amgen, Vertex Pharmaceuticals, Illumina, Biogen, Regeneron, CRISPR Therapeutics, Sangamo Therapeutics, Inc., bluebird bio, Intellia Therapeutics, Inc., Editas Medicine +42 more (view full list) |
Looking for a particular Abalone Bio employee's phone or email?
Richard Yu is the Co-founder and CEO of Abalone Bio.
17 people are employed at Abalone Bio.
Abalone Bio is based in Emeryville, California.